Variant report
Variant | nsv525865 |
---|---|
Chromosome Location | chr4:81864371-81894986 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-BMP3-2 | chr4:81884671-81884851 | NONHSAT097143 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6830629 | chr4:81864371-81864372 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs550254109 | chr4:81864398-81864399 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs566972343 | chr4:81864423-81864424 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs34563149 | chr4:81864430-81864431 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs535825305 | chr4:81864501-81864502 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs552882019 | chr4:81864558-81864559 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs566723340 | chr4:81864580-81864581 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs557690851 | chr4:81864589-81864590 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs148686297 | chr4:81864598-81864599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs187049309 | chr4:81864626-81864627 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs191122409 | chr4:81864635-81864636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs577870280 | chr4:81864667-81864668 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs557485833 | chr4:81864671-81864672 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs112275993 | chr4:81864680-81864681 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs182365142 | chr4:81864712-81864713 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs543010790 | chr4:81864757-81864758 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs187053217 | chr4:81864765-81864766 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs191648835 | chr4:81864779-81864780 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs183062360 | chr4:81864818-81864819 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs371788109 | chr4:81864819-81864820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs35642310 | chr4:81864900-81864901 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs111750628 | chr4:81864917-81864918 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs113309012 | chr4:81865004-81865005 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs142180905 | chr4:81865019-81865020 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs199561559 | chr4:81865047-81865048 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs373801427 | chr4:81865060-81865061 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs187302226 | chr4:81865069-81865070 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs193132085 | chr4:81865080-81865081 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs185737959 | chr4:81865088-81865089 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs112100216 | chr4:81865089-81865090 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs533469256 | chr4:81865147-81865148 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs190267406 | chr4:81865151-81865152 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs558562521 | chr4:81865152-81865153 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs569078849 | chr4:81865164-81865165 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs192715679 | chr4:81865177-81865178 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs571872514 | chr4:81865218-81865219 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs564743898 | chr4:81865219-81865220 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs557508023 | chr4:81865259-81865260 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs556184285 | chr4:81865260-81865261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs141268954 | chr4:81865295-81865296 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs543047750 | chr4:81865327-81865328 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs183631825 | chr4:81865328-81865329 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs573149254 | chr4:81865329-81865330 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs545732846 | chr4:81865352-81865353 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs570230599 | chr4:81865364-81865365 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs145138184 | chr4:81865369-81865370 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs575831087 | chr4:81865385-81865386 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs544364516 | chr4:81865390-81865391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs560669251 | chr4:81865396-81865397 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs529691830 | chr4:81865452-81865453 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Gastric cancer | 16891809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:81864000-81864400 | Enhancers | NHDF-Ad | bronchial |
2 | chr4:81864400-81867600 | Weak transcription | NHDF-Ad | bronchial |
3 | chr4:81866200-81866400 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
4 | chr4:81866200-81866400 | Enhancers | Ovary | ovary |
5 | chr4:81866400-81870800 | Weak transcription | Ovary | ovary |
6 | chr4:81867000-81867200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
7 | chr4:81867400-81871200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr4:81867600-81871800 | Enhancers | NHDF-Ad | bronchial |
9 | chr4:81869200-81870600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr4:81870800-81871200 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
11 | chr4:81870800-81871200 | Enhancers | Ovary | ovary |
12 | chr4:81871200-81872000 | Enhancers | Fetal Kidney | kidney |
13 | chr4:81882800-81883200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr4:81884000-81884800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
15 | chr4:81884000-81884800 | Enhancers | NHEK | skin |
16 | chr4:81884200-81884600 | Enhancers | NHDF-Ad | bronchial |
17 | chr4:81887000-81887600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
18 | chr4:81887600-81888400 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
19 | chr4:81888400-81889000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
20 | chr4:81888600-81889200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
21 | chr4:81888800-81889000 | Bivalent Enhancer | NHDF-Ad | bronchial |
22 | chr4:81894800-81895600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |